Dyadic International, Inc.
(NASDAQ : DYAI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. -3.06%240.131.3%$818.31m
MRNAModerna, Inc. -4.07%67.030.0%$732.25m
NVAXNovavax, Inc. 1.06%109.5096.5%$701.25m
IMMUImmunomedics, Inc. 0.06%85.5811.0%$601.32m
GILDGilead Sciences, Inc. -1.86%63.841.0%$588.00m
REGNRegeneron Pharmaceuticals, Inc. -1.27%548.192.7%$439.45m
VRTXVertex Pharmaceuticals, Inc. -1.49%261.431.9%$324.26m
BIIBBiogen, Inc. -2.83%266.731.6%$323.57m
ILMNIllumina, Inc. -7.01%274.803.5%$291.16m
SRNESorrento Therapeutics, Inc. -1.49%9.291.5%$270.74m
ALXNAlexion Pharmaceuticals, Inc. -2.85%110.482.0%$258.95m
MNTAMomenta Pharmaceuticals, Inc. 0.18%52.363.0%$237.79m
BMRNBioMarin Pharmaceutical, Inc. -2.91%77.074.3%$232.52m
VXRTVaxart, Inc. 7.79%8.860.0%$230.20m
SGENSeattle Genetics, Inc. -1.70%177.876.0%$190.86m

Company Profile

Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.